To investigate whether the association between miR-494 and TFPI-2 could be relevant in a clinical setting, we examined the relationship between TFPI-2 mRNA and miR-494 levels in tumors from breast cancer patients. This evidence concerns the gene TFPI2 and breast carcinoma.